The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease

The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease

Ming Zhang,1 Jingjing Tang,1 Jiafeng Yin,2 Xiaoying Wang,3 Xiangli Feng,1 Xia Yang,1 Hu Shan,1 Qiuhong Zhang,1 Jie Zhang,1 Yali Li1 1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 2Department of Laborator...

Full description

Bibliographic Details
Main Authors:	Zhang M, Tang J, Yin J, Wang X, Feng X, Yang X, Shan H, Zhang Q, Zhang J, Li Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-01-01
Series:	International Journal of COPD
Subjects:	chronic obstructive pulmonary disease inflammation cyclophilin A C-reactive protein
Online Access:	https://www.dovepress.com/the-clinical-implication-of-serum-cyclophilin-a-in-patients-with-chron-peer-reviewed-article-COPD

Similar Items

Serum inflammatory markers and nutritional status in patients with stable chronic obstructive pulmonary disease
by: Sneh Arora, et al.
Published: (2019-01-01)

Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
by: Philippe Gallay, et al.
Published: (2012-10-01)

Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome
by: Hang Zhang, et al.
Published: (2017-12-01)

Cyclophilins A, B, and C Role in Human T Lymphocytes Upon Inflammatory Conditions
by: Sandra Gegunde, et al.
Published: (2021-03-01)

Over-expression of nuclear factor-κB family genes and inflammatory molecules is related to chronic obstructive pulmonary disease
by: Zhou L, et al.
Published: (2018-07-01)

Assessment of serum interleukin 6 level in patients with chronic obstructive pulmonary disease: is it related to disease severity?
by: Esmat A. Abd Elnaby, et al.
Published: (2020-01-01)

Mitochondrial alterations during oxidative stress in chronic obstructive pulmonary disease
by: Jiang Y, et al.
Published: (2017-04-01)

Serum Glycerophospholipid Profile in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Xiaoyan Gai, et al.
Published: (2021-02-01)

Cyclophilins as Modulators of Viral Replication
by: Stephen D. Frausto, et al.
Published: (2013-07-01)

ROLE OF SYSTEMATIC INFLAMMATION IN THE DEVELOPMENT OF COMORBIDITY IN CASE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2017-06-01)

Pulmonary Function Influences the Performance of Berlin Questionnaire, Modified Berlin Questionnaire, and STOP-Bang Score for Screening Obstructive Sleep Apnea in Subjects with Chronic Obstructive Pulmonary Disease
by: Wu Q, et al.
Published: (2020-05-01)

The processes of inflammation and fibrosis in patients with chronic obstructive pulmonary disease
by: T.A. Pertseva, et al.
Published: (2020-12-01)

Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis
by: Khai Gene Leong, et al.
Published: (2021-12-01)

Cyclophilin A Promotes Inflammation in Acute Kidney Injury but Not in Renal Fibrosis
by: Khai Gene Leong, et al.
Published: (2020-05-01)

Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan
by: Chu-Hsu Lin, et al.
Published: (2018-01-01)

Identification of Metabolism-Associated Molecular Subtypes of Chronic Obstructive Pulmonary Disease
by: Hu Y, et al.
Published: (2021-08-01)

Chronic obstructive pulmonary disease concurrent with metabolic syndrome: Pathophysiological and clinical features
by: A V Budnevsky, et al.
Published: (2017-01-01)

Serum bilirubin and the risk of chronic obstructive pulmonary disease exacerbations
by: Kirstin E. Brown, et al.
Published: (2017-10-01)

The relationship between metabolic syndrome and chronic obstructive pulmonary disease
by: Therese Ghatas
Published: (2017-01-01)

Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease
by: Diao W, et al.
Published: (2019-09-01)

Eosinophils as a non-invasive marker to assess inflammatory activities in those suffering from chronic obstructive pulmonary disease
by: M. A. Kаrnаushkinа, et al.
Published: (2018-11-01)

Comparing frequencies of asthma-chronic obstructive pulmonary disease overlap in patients with stable chronic obstructive pulmonary disease
by: Nezar R. Mohamed, et al.
Published: (2019-07-01)

Review of the association between periodontitis and chronic obstructive pulmonary disease in smokers
by: Agathi Spiropoulou, et al.
Published: (2019-03-01)

Relationship between serum procalcitonin level and chronic obstructive pulmonary disease
by: Hamid Borsi, et al.
Published: (2019-01-01)

Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease
by: Wang H, et al.
Published: (2016-09-01)

The influence of adequate drug therapy on the clinical symptoms and level of serum amyloid A in patients with chronic obstructive pulmonary disease.
by: T. A. Pertseva, et al.
Published: (2018-05-01)

The Reliability and Validity of the Brief ICF Core Set in Patients with Chronic Obstructive Pulmonary Disease
by: Zhang Y, et al.
Published: (2021-07-01)

Effectiveness and Economic Evaluation of Hospital-Outreach Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease
by: Zhang A, et al.
Published: (2020-05-01)

Increased Serum Soluble Interleukin-2 Receptor Associated with Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Zhang Y, et al.
Published: (2021-09-01)

Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis
by: Jia Wei, et al.
Published: (2015-08-01)

CYCLOPHILIN A: STRUCTURE AND FUNCTIONS
by: A. A. Kalinina, et al.
Published: (2017-12-01)

PHYSICAL TRAINING IS A UNIVERSAL METHOD OF PULMONARY REHABILITATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N N Mescheryakova, et al.
Published: (2012-03-01)

Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity
by: E. S. Ovsyannikov, et al.
Published: (2020-03-01)

CYTOTOXIC LYMPHOCYTES: THE ROLE IN INFLAMMATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION AND REMISSION
by: N. A. Raspopina, et al.
Published: (2016-02-01)

The etiologic origins for chronic obstructive pulmonary disease
by: Huang X, et al.
Published: (2019-05-01)

Anemias in chronic obstructive pulmonary disease
by: A V Budnevsky, et al.
Published: (2016-03-01)

Cyclophilin D‐dependent mitochondrial permeability transition amplifies inflammatory reprogramming in endotoxemia
by: Balazs Veres, et al.
Published: (2021-03-01)

Association between blood pressure, inflammation and spirometry parameters in chronic obstructive pulmonary disease
by: Sulhattin Arslan, et al.
Published: (2019-01-01)

Role of neutrophil to lymphocyte ratio in prediction of acute exacerbation of chronic obstructive pulmonary disease
by: Aida M. Yousef, et al.
Published: (2017-01-01)

Pulmonary embolism with chronic obstructive pulmonary disease
by: Ruohan Yang, et al.
Published: (2021-09-01)